Biora Therapeutics finishes restructuring, now privately held with funds to boost BioJet™ platform development.
After completing a restructuring process, Biora has transitioned into a privately owned company. The company has secured long-term funding that will be utilized to expedite the advancement of the BioJet™ platform. This move signals a significant milestone for Biora as they focus on enhancing their technology. The specific amount of financing and other details surrounding the transition were not disclosed publicly.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments